BSE filing, NSE: SULA. Summary written from the filing by ALFA Finder's alert engine.
Sula Vineyards Ltd: key numbers
- Share price
- ₹137.77
- Market cap
- ₹1,163 Cr
- Revenue (annual)
- ₹555.9 Cr
- Net profit (annual)
- ₹25.65 Cr
- P/E (TTM)
- 47.0×Sector 28.6×
- Promoter holding
- 24.62%+0.00% QoQ
- FII holding
- 0.35%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Sula Vineyards Ltd
All →Sula Vineyards Investor Presentation: Key Takeaways
Q2 FY27: net revenue INR 135.5 Cr (+4% YoY), operating EBITDA INR 27.5 Cr (+8%), PAT INR 8.1 Cr (+34%). Premiumisation continues; Elite & Premium is 82% of own brands.
Sula Vineyards Capacity Expansion: ₹25 Cr Investment
Sula Vineyards plans a 30-40 room hotel at York Winery, costing about Rs 25 crore by March 2028. The board also approved Q2 results and de-alcoholised wine diversification.
- Value
- ₹25.00 Cr
- Execution
- Completion by March 2028
- hotel rooms
- 30.0 rooms
Sula Vineyards Q2 FY27 Results: Net Profit ₹8.1 Cr, Up 35.0% YoY
Sula Vineyards Ltd reported revenue from operations of ₹145.4 Cr (+4.1% YoY) and net profit of ₹8.1 Cr (+35.0% YoY) for Q2 FY27.
- Key figure
- Net profit ₹8.1 Cr · +35.0% YoY
Sula Vineyards Board Meeting Date
Sula Vineyards schedules a board meeting on 05 Nov 2026 to consider September 2026 quarter and half-year financial results. The trading window stays closed until 07 Nov 2026.
Sula Vineyards Other Announcement
Sula Vineyards Ltd has submitted its quarterly shareholding pattern for the period ending September 30, 2026, as required by SEBI regulations.
Sula Vineyards Annual General Meeting
Sula Vineyards Ltd reported the voting results of its Postal Ballot, where shareholders approved the appointment and commission payment for Mr. Chaitanya Rathi.
Other results update announcements
All →Paras Healthcare Results Update
Paras Healthcare reported Q2 FY27 revenue of Rs. 510.9 crore, up 22.8% YoY, through a press release. These are its first results since its October 2026 listing.
AstraZeneca Pharma India Results Update
AstraZeneca Pharma India reported 30% growth in Q2 results, with three new regulatory approvals. It also announced MoUs with two state governments.
BCPL Railway Infrastructure Results Update
BCPL Railway's H1 FY27 standalone revenue fell 7.80% to Rs 4,982.46 lacs, while consolidated revenue rose 26.44% to Rs 16,209.53 lacs. Consolidated PAT was Rs 527.66 lacs.
Meta Infotech Results Update
Meta Infotech's H1FY27 revenue fell 57% YoY to Rs 895 Million, while PAT was Rs 49 Million. Gross margin improved to 32.2% as it shifted toward services.
B.R.Goyal Infrastructure Results Update
B.R.Goyal Infrastructure released H1 FY27 unaudited results, with revenue up 60.67% and PAT up 37.82%. Order book stood at Rs 1,755 Crore on September 30, 2026.
Britannia Industries Results Update
Britannia reported Q2 consolidated sales of Rs 5,542 Crore (up 16.6%) and net profit of Rs 726 Crore (up 10.8%). Six-month sales reached Rs 10,506 Crore with profit at Rs 1,319 Crore.